{"_canonicalization":{"envelope_id":"axm_ + sha256(envelope minus {signature, axiom_id, anchors})","envelope_signature":"ed25519(envelope minus {signature, axiom_id})","json":"sort_keys=True, separators=(',',':'), ensure_ascii=False, allow_nan=False, utf-8","leaf_hash":"sha256(0x00 || canonical_json(envelope_full))","seal_signature":"ed25519(seal minus {signature, sig_algorithm})"},"axiom_id":"axm_0120823bd280b3b5495b1ef864197de5b830d71b25173567bbf5edfb1baf4296","bitcoin_anchor":{"bitcoin_attestations":[],"calendar_attestations":[],"ots_url":"","stamped_at":"","status":"pending_next_stamp"},"envelope":{"anchors":[{"chain":"crovia.axiom_graph","height":0,"merkle_proof":"spider_vendor_press_v1","root_at_anchor":"spider_vendor_press_v1"}],"axiom_id":"axm_0120823bd280b3b5495b1ef864197de5b830d71b25173567bbf5edfb1baf4296","axiom_type":"AX.OBS","body":{"axiom_subtype":"news.vendor_press.v1","category":"news","fingerprint":"eaf058a84df573179b0f6e2e209082c6372719289fef091b122a81e979efe51f","published":"Tue, 19 May 2026 00:00:00 -0400","receipt_hash":"eaf058a84df573179b0f6e2e209082c6372719289fef091b122a81e979efe51f","schema":"spider.news.vendor_press.v1","spider":"vendor_press","spider_record":{"axiom_subtype":"news.vendor_press.v1","category":"news","decision_hint":"POSITIVE","envelope_target":"AX.OBS","fingerprint":"eaf058a84df573179b0f6e2e209082c6372719289fef091b122a81e979efe51f","observed_at":"2026-05-19T04:43:36.782648Z","parent_run_hash":"fefa4c726316a95c5dda9fc1ca07a38a811cf7ffa9825b2f09b365abacd9b32d","published":"Tue, 19 May 2026 00:00:00 -0400","runtime_version":"0.1.0","schema":"spider.news.vendor_press.v1","source_status":200,"source_url":"https://export.arxiv.org/rss/cs.AI","spider":"vendor_press","summary_excerpt":"arXiv:2601.02071v3 Announce Type: replace \nAbstract: Pharmaceutical three-dimensional (3D) printing is an advanced fabrication technology with the potential to enable truly personalised dosage forms. Recent studies have integrated artificial intelligence (AI) to accelerate formulation and process development, drastically transforming current approaches to pharmaceutical 3D printing. To date, most AI-driven efforts remain narrowly focused, while failing to account for the broader formulation challenges inherent to the technology. Recent advances in AI have introduced artificial general intelligence concepts, wherein systems extend beyond conventional predictive modelling toward more generalised, human-like reasoning. In this work, we investigate the application of large language models (LLMs), fine-tuned on a fused deposition modelling (FDM) dataset comprising over 1400 formulations, to recommend suitable excipients based on active pharmaceutical ingredient (API) dose, and predict filam","title":"FormuLLA: A Large Language Model Approach to Generating Novel 3D Printable Formulations","url":"https://arxiv.org/abs/2601.02071","vendor":"arxiv_cs_ai"},"summary":"arXiv:2601.02071v3 Announce Type: replace \nAbstract: Pharmaceutical three-dimensional (3D) printing is an advanced fabrication technology with the potential to enable truly personalised dosage forms. Recent studies have integrated artificial intelligence (AI) to accelerate formulation and process development, drastically transforming current approaches to pharmaceutical 3D printing. To date, most AI-driven efforts remain narrowly focused, while failing to account for the broader formulation challenges inherent to the technology. Recent advances in AI have introduced artificial general intelligence concepts, wherein systems extend beyond conventional predictive modelling toward more generalised, human-like reasoning. In this work, we investigate the application of large language models (LLMs), fine-tuned on a fused deposition modelling (FDM) dataset comprising over 1400 formulations, to recommend suitable excipients based on active pharmaceutical ingredient (API) dose, and predict filam","title":"FormuLLA: A Large Language Model Approach to Generating Novel 3D Printable Formulations","vendor":"arxiv_cs_ai"},"confidence":{"method":"deterministic"},"decision":"POSITIVE","issued_at":"2026-05-19T04:43:36Z","notes":"Spider vendor_press (news) news.vendor_press.v1","object":{"captured_by":"crovia.spider.vendor_press","primary_source_url":"https://arxiv.org/abs/2601.02071"},"predecessors":[],"schema":"crovia.axiom.v1","signature":"ed25519:8cc54899cc39fc9d63cedbfce153a25d3d07d6c480335bc5c2a5156176ce5f9c0a02b8d771282dd32bd290a64ea9384f7a07291b04b7f380aa14b3e2fca23703","signer":"crovia.substrate","subject":{"observed_at":"2026-05-19T04:43:36Z","source_collector":"spider:vendor_press","target_id":"https://arxiv.org/abs/2601.02071"},"tsa":{"authority":"crovia.substrate.bootstrap","rfc3161_token":"{\"kind\":\"crovia.bootstrap.tsa\",\"source_jsonl\":\"/opt/crovia/spider/data/news/vendor_press_v1.jsonl\",\"source_seal_merkle_root\":\"spider_vendor_press_v1\",\"upgrade_path\":\"Sessione H \\u2014 OpenTimestamps weekly anchor\"}"},"zk_mode":"clear","zk_proof":null},"ledger":{"leaf_hash":"71069d2fdaa4ecc4f2b163326d701902195802ddf28483dd00f65ee3271b557e","leaf_index":142946,"ledger_path":"/opt/crovia/substrate/axiom_ledger.jsonl"},"merkle_proof":{"hash_alg":"sha256","leaf_prefix":"0x00","node_prefix":"0x01","odd_leaf_rule":"duplicate_last","path":[{"sibling":"a6502f0ec6137898f13edfbaace295d842c1915dd28c112ab462ec48f4fb2f4b","side":"right"},{"sibling":"80a46774324ad7be90a188328fee53ccefd5afe29ead04938070692f9262c784","side":"left"},{"sibling":"ecf37d5f20a942b560aea816f7948b2809ce6dde8a632c51bfce965ebb22370c","side":"right"},{"sibling":"9380adb8bf2cefb0584b48d014dc045d19a86b275e7967d23bb7854a07dfb8da","side":"right"},{"sibling":"5d66455999949b75b76491bd5509b46200de9adfb92742abfe69399eb6beb4c4","side":"right"},{"sibling":"3f9a5345017ea65e5d058e222a647991f120e8ad55377a6ea03ee8db431d977d","side":"left"},{"sibling":"18920e627055779d158c7c223ef853d7d69b12953cbd8e0326b3401e85b3e0a0","side":"left"},{"sibling":"1d2edc28d27d4c312510482f7321ca401bdfe21a8e83916a1ba677f0ea4fcd2b","side":"right"},{"sibling":"78a19962a2f444f055541381645626e3d4e1c8c7c2811bf54eeb89100f89f5b2","side":"right"},{"sibling":"db97141c585f6a1e6bebe92b3ea300ea0f38a2321ca286d85850b11b2dd162a6","side":"left"},{"sibling":"202f1bead178ef3785968d50d3d188264a95192a077654c331612e04a34cbfbe","side":"left"},{"sibling":"72249c8c8b068386e35d16f4bd0bbeb9ba820ca217ef0f0d28396c9fe493f5f0","side":"left"},{"sibling":"ea64599340f7ffdf17ad0cbc1d9401ef8870a347e3847bdc106d06b1673df09c","side":"right"},{"sibling":"8f4c0fbe56b6c010fbb8c782ebcd478079bb3f991d8704e2534209a075d9163c","side":"left"},{"sibling":"4db1f363729507e27a60851cf6ed334d7b9acdef194ed7d419aba4d2bd367a4a","side":"right"},{"sibling":"a86ee18c45e7fcc408b6007eaece05aa75b2d9ae30252e9e878462b4dffbef7b","side":"right"},{"sibling":"1d18e7663d43ccff0122ecc7ee12645bb16afb607b218e81b1ea2408f863cb78","side":"right"},{"sibling":"d841ad93efda0869e5eb97678f348f03f5caab4353e05ff4bf18f47fb945b822","side":"left"}]},"schema":"crovia.axiom_proof.v1","seal":{"first_collector_run_id":"","first_receipt_hash":"","jsonl_path":"/opt/crovia/substrate/axiom_ledger.jsonl","key_id":"430895f101d38164","last_collector_run_id":"","last_receipt_hash":"","leaf_count":143302,"merkle_root":"999156d40a7c61d9ddd52b7338f3cbda3e68f53bace070c7b616ea194e23b123","public_key_hex":"cf742e26f75669dc673cb5c0786a1ae23ae8ca19c347317192ce40c28a7ff25c","run_id":"hourly_json_retrofit_20260519T053701Z","schema":"crovia.seal.v1","seal_family_version":"crovia-seal-family/1","seal_kind":"substrate_batch","sealed_at":"2026-05-19T05:37:30Z","sig_algorithm":"ed25519","signature":"b1a252cc66ff32bed1d10dd88a6b2a200e3856d3dbcfcc4ee55e02e00f3d548e854ed9c544704b222bd5d315492c4a935ba2d90d727c585a67899b0ad602fc05","signer_version":"1.1.0"},"trust_root":{"key_id":"430895f101d38164","public_key_hex":"cf742e26f75669dc673cb5c0786a1ae23ae8ca19c347317192ce40c28a7ff25c","signature_algorithm":"ed25519","url":"/registry/canon/TRUST_ROOT.md"},"verifier":{"spec":"/registry/canon/AXIOM_RECEIPT_v1.md","url":"/v/axm_0120823bd280b3b5495b1ef864197de5b830d71b25173567bbf5edfb1baf4296"}}